Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: FCHSD1 is a member of the F-BAR family containing one amino terminal F-BAR domain and two SH3 domains. At present, there are no relevant pan-cancer comprehensive studies on the predictive potential and immune infiltration of FCHSD1 for cancer.
Methods: FCHSD1 expression profiles were analyzed through the use of various tools, including TIMER, GEPIA, R packages, and the UALCAN database. The genetic alteration status of FCHSD1 in human pan-cancer was studied using the cBioPortal website. The effect of FCHSD1 on immune infiltration was examined using the TIMER and TISIDB databases. We confirmed the association between FCHSD1 expression and patient prognosis using survival analysis from GEPIA and R packages. The drug database was utilized to analyze the sensitivity of FCHSD1 to drugs. The FCHSD1 interactive genes were obtained through the STRING and GeneMANIA platforms, respectively, and analyzed by GO and KEGG. The expression and function of FCHSD1 in renal cancer cells and tissues have also been biologically validated .
Results: FCHSD1 expression was found to be elevated in tumor tissues compared to adjacent tissues. The expression of FCHSD1 varied across different clinical stages, pathological stages, immune types, and molecular subtypes. Higher expression of FCHSD1 predicts worse outcomes for several cancer types, such as CHOL and KIRC. High FCHSD1 expression was positively correlated with immune cell infiltration in different cancer types. Additionally, the FCHSD1 co-expression gene network may be involved in endocytosis. experiments revealed that the expression of FCHSD1 in renal cancer cells and tissues was higher than that in normal cells and adjacent non-cancerous tissues. Functional assays revealed that FCHSD1 knockdown significantly suppressed proliferation and migration in ACHN and 769P cells.
Conclusion: FCHSD1 has the potential to serve as a prognostic and immunological marker for pan-cancer, and may also be a crucial target for future immunotherapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12173925 | PMC |
| http://dx.doi.org/10.3389/fonc.2025.1547067 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis.
Front Oncol
June 2025
Department of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.
Background: FCHSD1 is a member of the F-BAR family containing one amino terminal F-BAR domain and two SH3 domains. At present, there are no relevant pan-cancer comprehensive studies on the predictive potential and immune infiltration of FCHSD1 for cancer.
Methods: FCHSD1 expression profiles were analyzed through the use of various tools, including TIMER, GEPIA, R packages, and the UALCAN database.
Key genes and immune infiltration patterns and the clinical implications in psoriasis patients.
Skin Res Technol
August 2024
Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Background: Psoriasis is an immune-mediated skin disease, closely related to immune regulation. The aim was to understand the pathogenesis of psoriasis further, reveal potential therapeutic targets, and provide new clues for its diagnosis, treatment, and prevention.
Materials And Methods: Expression profiling data were obtained from the Gene Expression Omnibus (GEO) database for skin tissues from healthy population and psoriasis patients.
Genetic predisposition to porto-sinusoidal vascular disorder.
Hepatology
June 2024
Université Paris-Cité, Inserm, Centre de recherche sur l'inflammation, UMR 1149, Paris, France.
Porto-sinusoidal vascular disorder (PSVD) is a rare liver disease. The pathophysiological mechanisms underlying the development of PSVD are unknown. Isolated cases of PSVD associated with gene mutations have been reported, but no overview is available.
View Article and Find Full Text PDFDifferentially Expressed mRNA in Streptozotocin-Induced Diabetic Bladder Using RNA Sequencing Analysis.
Int Neurourol J
September 2023
Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul, Korea.
Purpose: To detect elements governing the pathogenesis of diabetic cystopathy (DC), mRNA sequencing was carried out for bladder tissues from normal rats and those with induced diabetes mellitus (DM). This research therefore offers possible underlying molecular pathways for the advancement of DC in relation to differential mRNA expression, together with visceral functional and architectural alterations noted in individuals with this condition.
Methods: An intraperitoneal injection of streptozotocin (STZ) was utilized to provoke DM in male Sprague-Dawley rats.
Machine learning-based prediction models for atopic dermatitis diagnosis and evaluation.
Fundam Res
May 2025
Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease seriously affecting the quality of life of patients. Reliable and accurate evaluation methods are necessary for early diagnosis and effective AD treatment. Thus, this study used machine learning (ML) to explore a novel diagnostic and therapeutic effect evaluation model for AD.
View Article and Find Full Text PDF